New! ASNC Publishes Comprehensive Information Statement on Imaging and Cancer

Approximately 14.5 million people with a current or prior cancer diagnosis are living in the United States today, and the National Cancer Institute expects this population to grow to 19 million in the next decade. A new information statement published by ASNC helps cardiologists, cardiac imaging specialists, cardio-oncologists and oncologists understand the implications of a cancer history on patients' current and future cardiovascular care. In this comprehensive statement, clinicians will find— 
  • Thorough discussion of the potentially life-threatening cardiopulmonary complications of cancer therapies, including the agents most likely to cause cardiotoxicity;
  • Detailed review of the nuclear cardiology techniques shown to reduce the incidence and severity of heart failure associated with chemotherapy;
  • Recommendations for monitoring cancer patients for cardiotoxicity and other cardiac complications;
  • Forecasting on the future role of nuclear cardiology in the diagnosis and treatment of cancer-related cardiovascular complications, including the prospect of using radiolabeled tracers to identify molecular treatment targets; and
  • An overview of the new and rapidly growing field of cardio-oncology.
“The ASNC cardio-oncology information statement is designed to provide practitioners with a guide to how nuclear cardiology can be used to advance and support the care of individuals who have cancer now or had cancer in the past,” says Raymond R. Russell, MD, PhD, FASNC, the statement's lead author. “This knowledge will be increasingly important for imaging specialists to have, especially as the population of cancer survivors continues to grow. We need to be prepared to provide for their unique cardiovascular care needs.”

DOWNLOAD “The Role and Clinical Effectiveness of Multimodality Imaging in the Management of Cardiac Complications of Cancer and Cancer Therapy.”